Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.
Blood cancer discovery·2026
Same author
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
European journal of haematology·2021
Same author
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
American journal of hematology·2021
Same author
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
Clinical lymphoma, myeloma & leukemia·2020
Same author
An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment - validation of official dosing guidelines.
Leukemia & lymphoma·2020
Same journal
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Blood·2026
Same journal
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.
Blood·2026
Same journal
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.
Blood·2026
Same journal
How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.
Blood·2026